THP为主的联合方案治疗原发性支气管肺癌252例的临床观察

The Clinical Observation in Primary Bronchogenic Lung Cancer 252 Cases Treated by THP of Principal Combination Regimes

摘要: 本文报道以THP为主的联合方案治疗原发支气管性肺癌252例.鳞癌用CTP方案,CR＋PR56.58%,腺癌用FTM方案,CR＋PR50.0%,小细胞癌用CTO方案,CR＋PR68.29%,各型有效率与通常报道相似.全组病例毒副作用较轻,脱发和心电图变化的发生率与程度较文献报道都低.THP是蒽环类理想的抗癌药物之一.

Abstract: This paper is reported the primary bronchogenic lung cancer 252 cases is treated by the THP of principal combination regimes.The squamous ce-ll cancer is used by CTP regimes,CR+PR 56.58%,adenose cell cancer is used by FTM regimes,CR+PR 50.0% and small cell cancer is used by CTO re-gimes,CR+PR68.29%.The response rate of various type was similarity for common reports.The appearance rate and degree of alopecia and the cha-nges of ECG were lower than the reported literatures.THP is one of ideal anti-cancer drug in anthracylcines.